|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...3536373839404142434445...110111» |
- |||| metformin hydrochloride extended release / Generic mfg.
Trial primary completion date: Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS) (clinicaltrials.gov) - Nov 28, 2015
P3, N=124, Recruiting, Sponsor: Dexa Medica Group
Trial primary completion date: Jan 2016 --> Jan 2017
- Enrollment change, Trial termination: Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae (clinicaltrials.gov) - Nov 28, 2015
P=N/A, N=2296, Terminated, Sponsor: Siemens Healthcare Diagnostics Inc
Trial primary completion date: Jan 2016 --> Jan 2017 N=3000 --> 2296 | Recruiting --> Terminated; Siemens Management decided not to release the product in the USA.
- Trial termination, Trial primary completion date: Sexual Functioning After Primary Treatment of Ovarian Cancer (clinicaltrials.gov) - Nov 27, 2015
P=N/A, N=18, Terminated, Sponsor: Memorial Sloan Kettering Cancer Center
N=3000 --> 2296 | Recruiting --> Terminated; Siemens Management decided not to release the product in the USA. Active, not recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Nov 2015; Lack of accrual
- ||||||| Visanne (dienogest) / Mochida, Bayer
Trial completion: Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients (clinicaltrials.gov) - Nov 26, 2015
P3, N=250, Completed, Sponsor: Bayer
Active, not recruiting --> Terminated | Trial primary completion date: Nov 2016 --> Nov 2015; Lack of accrual Active, not recruiting --> Completed
- Enrollment closed: SeTPAT: Treponema Pallidum-specific Proteomic Changes in Patients With Incident Syphilis Infection (clinicaltrials.gov) - Nov 26, 2015
P=N/A, N=150, Active, not recruiting, Sponsor: Institute of Tropical Medicine, Belgium
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Androgen Metabolism and Reproductive Outcome (clinicaltrials.gov) - Nov 26, 2015
P=N/A, N=400, Completed, Sponsor: Medical University of Graz
Recruiting --> Active, not recruiting Recruiting --> Completed
- || Talzenna (talazoparib) / Pfizer
Enrollment change, Trial primary completion date, Metastases: Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors (clinicaltrials.gov) - Nov 24, 2015
P1, N=113, Active, not recruiting, Sponsor: BioMarin Pharmaceutical
Recruiting --> Completed N=85 --> 113 | Trial primary completion date: Dec 2014 --> Jan 2016
- || Trial primary completion date: Multicenter Italian Validation of EHP-30 (clinicaltrials.gov) - Nov 24, 2015
P=N/A, N=200, Recruiting, Sponsor: University of Cagliari
N=85 --> 113 | Trial primary completion date: Dec 2014 --> Jan 2016 Trial primary completion date: Sep 2015 --> Sep 2016
- | New P4 trial: Syphilis Response to Higher Penicillin Dosage: The 2.4 Versus 7.2 Study (clinicaltrials.gov) - Nov 24, 2015
P4, N=68, Completed, Sponsor: Baylor College of Medicine
- ||||| Enrollment change: DESTINy: Diafert for Embryo Selection and Fertility Improvement (clinicaltrials.gov) - Nov 23, 2015
P3, N=60, Recruiting, Sponsor: Forest Laboratories
Trial primary completion date: Sep 2015 --> Sep 2016 N=180 --> 60
- Trial completion, Enrollment change: Patient Navigation in the Safety Net:CONNECTeDD (clinicaltrials.gov) - Nov 22, 2015
P4, N=4038, Completed, Sponsor: Boston Medical Center
N=180 --> 60 Active, not recruiting --> Completed | N=7648 --> 4038
- || Visanne (dienogest) / Mochida, Bayer
Trial primary completion date: Regulatory Post Marketing Surveillance Study in Korea (clinicaltrials.gov) - Nov 22, 2015
P=N/A, N=3750, Recruiting, Sponsor: Bayer
Active, not recruiting --> Completed | N=7648 --> 4038 Trial primary completion date: Dec 2017 --> Apr 2017
- ONT-10 / Seagen
Enrollment closed, Metastases: Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer (clinicaltrials.gov) - Nov 22, 2015
P1, N=42, Active, not recruiting, Sponsor: Oncothyreon Inc.
Trial primary completion date: Dec 2017 --> Apr 2017 Recruiting --> Active, not recruiting
- | adavosertib (AZD1775) / AstraZeneca
New P1 trial, Monotherapy, Metastases: Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours. (clinicaltrials.gov) - Nov 21, 2015
P1, N=18, Not yet recruiting, Sponsor: AstraZeneca
- |||| progesterone / Generic mfg.
Enrollment open, Head-to-Head: Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer (clinicaltrials.gov) - Nov 19, 2015
P4, N=1170, Recruiting, Sponsor: Shady Grove Fertility Reproductive Science Center
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Enrollment closed: Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications (clinicaltrials.gov) - Nov 19, 2015
P=N/A, N=1650, Active, not recruiting, Sponsor: Yale University
Not yet recruiting --> Recruiting Enrolling by invitation --> Active, not recruiting
- | carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Surgery, Metastases: S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer (clinicaltrials.gov) - Nov 19, 2015
P2, N=62, Completed, Sponsor: Southwest Oncology Group
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- ||| New trial: ARTIST: A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation (clinicaltrials.gov) - Nov 19, 2015
P=N/A, N=1000, Not yet recruiting, Sponsor: Merck KGaA
- Enrollment open, Biopsy: Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy (clinicaltrials.gov) - Nov 19, 2015
P=N/A, N=78, Recruiting, Sponsor: University of South Florida
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion, Retrospective data, Enrollment change, Trial primary completion date: Retrospective Database Studies (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=1, Completed, Sponsor: Reproductive Medicine Associates of New Jersey
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=10000 --> 1 | Trial primary completion date: Dec 2016 --> Oct 2015
- RebmAb 100 / Recepta
Trial termination: Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer (clinicaltrials.gov) - Nov 17, 2015
P2, N=29, Terminated, Sponsor: Recepta Biopharma
Active, not recruiting --> Completed | N=10000 --> 1 | Trial primary completion date: Dec 2016 --> Oct 2015 Completed --> Terminated; Total number of pts expected to be enrolled would not be met.
- Trial completion, Cytology: Anal HPV Infection and Abnormal Cytology in HIV-infected Women (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=100, Completed, Sponsor: Boston Medical Center
Completed --> Terminated; Total number of pts expected to be enrolled would not be met. Active, not recruiting --> Completed
- New trial: Understanding Adaptive Challenges Associated With Male-factor Infertility (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=20, Recruiting, Sponsor: Duke University
- Bravelle (urofollitropin) / Ferring
New P3 trial: Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia (clinicaltrials.gov) - Nov 16, 2015
P3, N=45, Not yet recruiting, Sponsor: Instituto de Investigacion Sanitaria La Fe
- Trial primary completion date: Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) - Nov 16, 2015
P4, N=500, Recruiting, Sponsor: Butler Hospital
Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Aug 2016
- Vigil (gemogenovatucel-T) / Gradalis
Trial primary completion date, Tumor cell: Salvage Ovarian FANG (clinicaltrials.gov) - Nov 15, 2015
P2, N=1, Active, not recruiting, Sponsor: Gradalis, Inc.
Trial primary completion date: Sep 2015 --> Aug 2016 Trial primary completion date: Jul 2015 --> Jul 2016
- Enrollment closed, Trial primary completion date, Surgery: Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery (clinicaltrials.gov) - Nov 15, 2015
P=N/A, N=130, Active, not recruiting, Sponsor: Swedish Medical Center
Trial primary completion date: Jul 2015 --> Jul 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Sep 2015
- sirolimus / Generic mfg.
Enrollment change: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (clinicaltrials.gov) - Nov 15, 2015
P1, N=30, Active, not recruiting, Sponsor: Roswell Park Cancer Institute
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Sep 2015 N=18 --> 30
- Enrollment closed, Trial primary completion date: Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer (clinicaltrials.gov) - Nov 15, 2015
P0, N=750, Active, not recruiting, Sponsor: Swedish Medical Center
N=18 --> 30 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Aug 2015
- || Enrollment change, BRCA Biomarker, IO biomarker: ENGAGE: Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer (clinicaltrials.gov) - Nov 14, 2015
P=N/A, N=400, Recruiting, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Aug 2015 N=800 --> 400
- ||||| Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
Enrollment closed, Trial primary completion date: SOLITAIRE-U: Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (clinicaltrials.gov) - Nov 14, 2015
P3, N=300, Active, not recruiting, Sponsor: Cempra Pharmaceuticals
N=800 --> 400 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Apr 2017
- clomifene citrate / Generic mfg.
Trial completion: Endometrial Shedding Prior to Ovulation Induction Pilot Study (clinicaltrials.gov) - Nov 14, 2015
P4, N=50, Completed, Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Apr 2017 Recruiting --> Completed
- New trial: Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence (clinicaltrials.gov) - Nov 14, 2015
P=N/A, N=95, Not yet recruiting, Sponsor: Rhode Island Hospital
- Preclinical, Enrollment change: Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation (clinicaltrials.gov) - Nov 12, 2015
P1/2, N=50, Completed, Sponsor: National and Kapodistrian University of Athens
Recruiting --> Completed N=80 --> 50
- Trial completion: needles(opu): Follicular Flushing Outcomes in Singles Versus Double Lumen Oocyte Retrieval Needles in Poor Responding Patients (clinicaltrials.gov) - Nov 11, 2015
P=N/A, N=80, Completed, Sponsor: Baskent University
N=80 --> 50 Not yet recruiting --> Completed
- Enrollment closed, Trial primary completion date, Head-to-Head: A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China (clinicaltrials.gov) - Nov 11, 2015
P=N/A, N=1168, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
Not yet recruiting --> Completed Not yet recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Jan 2016
- lidocaine 5% / Generic mfg.
Enrollment closed, Trial primary completion date: Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study (clinicaltrials.gov) - Nov 11, 2015
P1, N=30, Active, not recruiting, Sponsor: Oregon College of Oriental Medicine
Not yet recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Jan 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Mar 2016
- Trial primary completion date: Sexual Functioning After Primary Treatment of Ovarian Cancer (clinicaltrials.gov) - Nov 10, 2015
P=N/A, N=18, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Mar 2016 Trial primary completion date: Nov 2015 --> Nov 2016
- || letrozole / Generic mfg.
Trial primary completion date: Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma (clinicaltrials.gov) - Nov 10, 2015
P2, N=80, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Nov 2015 --> Nov 2016 Trial primary completion date: Dec 2016 --> Dec 2017
- Trial completion, Trial primary completion date: Endometrial Priming for Embryo Transfer (clinicaltrials.gov) - Nov 10, 2015
P4, N=140, Completed, Sponsor: Parc de Salut Mar
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | Trial primary completion date: Jun 2013 --> Oct 2014
- Trial completion, Trial primary completion date: Step Up Versus Step Down in Controlled Ovarian Stimulation (clinicaltrials.gov) - Nov 10, 2015
P4, N=158, Completed, Sponsor: Parc de Salut Mar
Recruiting --> Completed | Trial primary completion date: Jun 2013 --> Oct 2014 Recruiting --> Completed | Trial primary completion date: Jun 2013 --> Feb 2014
- Duomeisu (pegylated liposomal doxorubicin) / CSPC Pharma, veliparib (ABT-888) / AbbVie
Trial primary completion date, PARP Biomarker, Metastases: Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer (clinicaltrials.gov) - Nov 10, 2015
P1, N=58, Recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed | Trial primary completion date: Jun 2013 --> Feb 2014 Trial primary completion date: Dec 2015 --> Oct 2016
- ||||||| Entereg (alvimopan) / Merck (MSD)
Trial completion, Surgery: Accelerating Gastrointestinal Recovery (clinicaltrials.gov) - Nov 10, 2015
P3, N=134, Completed, Sponsor: Jamie N. Bakkum-Gamez
Trial primary completion date: Dec 2015 --> Oct 2016 Recruiting --> Completed
- Trial completion, Preclinical, Enrollment change: Stress Management for Couples Undergoing In Vitro Fertilization (IVF) (clinicaltrials.gov) - Nov 9, 2015
P2, N=60, Completed, Sponsor: Amit Sood
Recruiting --> Completed Recruiting --> Completed | N=80 --> 60
- Trial initiation date: PCS: Preventing Congenital Syphilis (clinicaltrials.gov) - Nov 8, 2015
P=N/A, N=6000, Not yet recruiting, Sponsor: Tulane University School of Public Health and Tropical Medicine
Recruiting --> Completed | N=80 --> 60 Initiation date: Apr 2015 --> Nov 2015
- Visanne (dienogest) / Mochida, Bayer
New P2/3 trial: Impact vs. Dienogest: A Combined Oral Contraceptive in the Size of Endometriomas (clinicaltrials.gov) - Nov 8, 2015
P2/3, N=50, Recruiting, Sponsor: Fundaci
- New P2 trial: Role of Three Dimensional Ultrasound in the Diagnosis of Septate Uterus (clinicaltrials.gov) - Nov 6, 2015
P2, N=38, Completed, Sponsor: Assiut University
- || New P3 trial: Pulmonary Recruitment Maneuver for Postlaparoscopic Shoulder Pain (clinicaltrials.gov) - Nov 5, 2015
P3, N=90, Recruiting, Sponsor: Kangbuk Samsung Hospital
- ||||||| Trial completion: Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women (clinicaltrials.gov) - Nov 5, 2015
P3, N=764, Completed, Sponsor: TherapeuticsMD
Initiation date: Apr 2015 --> Nov 2015 Active, not recruiting --> Completed
- || Trial primary completion date: Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. (clinicaltrials.gov) - Nov 5, 2015
P=N/A, N=75, Recruiting, Sponsor: Mauna Kea Technologies
Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Dec 2015